Conning Inc. Novartis Ag Transaction History

Conning Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 25, 2019	SELL	$75.4 - $92.8 $452,400 - $556,800	-6,000 Closed	0 $0
Q1 2019 Apr 22, 2019	BUY	$75.32 - $86.15 $451,919 - $516,900	6,000 New	6,000 $577,000
Q4 2018 Jan 29, 2019	SELL	$73.66 - $82.02 $417,873 - $465,299	-5,673 Closed	0 $0
Q2 2018 Jul 25, 2018	SELL	$64.91 - $73.36 $44,008 - $49,738	-678 Reduced 10.68%	5,673 $429,000
Q1 2018 May 04, 2018	SELL	$70.39 - $84.15 $18,019 - $21,542	-256 Reduced 3.87%	6,351 $513,000
Q4 2017 Jan 30, 2018	SELL	$72.33 - $77.64 $139,452 - $149,689	-1,928 Reduced 22.59%	6,607 $555,000
Q3 2017 Oct 20, 2017	BUY	$74.14 - $77.27 $632,784 - $659,499	8,535	8,535 $733,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Conning Inc., based on Form 13F filings with the SEC.

Stay updated on Conning Inc. with notifications on news.